Tumor-associated lymphatic endothelial cell promotes invasion of cervical cancer cells
- PMID: 23566114
- DOI: 10.1111/apm.12068
Tumor-associated lymphatic endothelial cell promotes invasion of cervical cancer cells
Abstract
The most common way for cervical cancer to spread is through the lymphatic system. Tumor-associated lymphatic endothelial cell (TLEC) has been considered to play a crucial role in metastasis of certain cancers. The aim of this study was to isolate TLEC from human cervical cancers and explore its involvement in metastasis-associated behaviors in vitro. Lymphatic vessels in 62 cervix tissue specimens ranging from cervical intraepithelial neoplasia (CIN) to advanced invasive cancer were detected using immunochemical staining with D2-40 antibody. Relation of lymphatic vessel density (LVD) to clinicopathological characters was analyzed. Primary TLECs were isolated by LYVE-1 immuno-magnetic beads from cervical cancer tissues and verified through expression of LEC markers Prox-1 and D2-40, and then cultured in vitro. Invasiveness and viability of cells were assessed by transwell assay and typan blue exclusion, respectively. Our results showed that higher LVD was significantly associated with advanced FIGO stage, pelvic lymphatic nodal metastasis (LNM), and poorer cell differentiation. TLECs were successfully primarily isolated and cultured in vitro. Supernatant of TLEC enhanced invasiveness of Hela cell, but did not significantly affect cell viability. In conclusion, TLECs might actively promote lymphatic metastasis of cervical cancer. Further studies are needed to demonstrate the underlying mechanisms.
Keywords: Cervical cancer; cell invasiveness; cell viability; lymphatic endothelial cell; lymphatic nodal metastasis; lymphatic vessel density.
© 2013 APMIS. Published by John Wiley & Sons Ltd.
Similar articles
-
Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.Pathology. 2010 Dec;42(7):629-36. doi: 10.3109/00313025.2010.522174. Pathology. 2010. PMID: 21080871
-
Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-IIa squamous cell cervical cancer.Cell Tissue Res. 2012 Jun;348(3):515-22. doi: 10.1007/s00441-012-1384-x. Epub 2012 Apr 11. Cell Tissue Res. 2012. PMID: 22492093
-
Identification of lymphatic vessels and prognostic value of lymphatic microvessel density in lesions of the uterine cervix.Rom J Morphol Embryol. 2009;50(4):589-94. Rom J Morphol Embryol. 2009. PMID: 19942952
-
Prox 1, VEGF-C and VEGFR3 expression during cervical neoplasia progression as evidence of an early lymphangiogenic switch.Histol Histopathol. 2012 Dec;27(12):1543-50. doi: 10.14670/HH-27.1543. Histol Histopathol. 2012. PMID: 23059885
-
Octamer binding transcription factor-4 expression is associated with cervical cancer malignancy and histological differentiation: a systematic review and meta-analysis.Biosci Rep. 2019 May 10;39(5):BSR20182328. doi: 10.1042/BSR20182328. Print 2019 May 31. Biosci Rep. 2019. PMID: 30979828 Free PMC article.
Cited by
-
PD-1 Blockade During Post-partum Involution Reactivates the Anti-tumor Response and Reduces Lymphatic Vessel Density.Front Immunol. 2019 Jun 11;10:1313. doi: 10.3389/fimmu.2019.01313. eCollection 2019. Front Immunol. 2019. PMID: 31244852 Free PMC article.
-
The Role of PROX1 in Neoplasia: A Key Player Often Overlooked.Diagnostics (Basel). 2022 Jul 4;12(7):1624. doi: 10.3390/diagnostics12071624. Diagnostics (Basel). 2022. PMID: 35885529 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous